In 2015 CMS started with the $42 typical reimbursement for 20 minutes per month multiple chronic condition (MCC) management (CCM) by phone or video. Doctors reported challenges of the administration (tracking, reporting, and billing) and several years of results has not yet shown clinical patient health outcomes improvements. The patient and doctors mostly feel the communications is better and some evidence of ER utilization reduction.
Accenture and Fair Health studies have seen around 80% of patients would prefer a virtual services capability. Many health systems and doctor groups lack the full spectrum of engineering, clinical, IT, and business expertise and bandwidth to develop an at home care model that provides more evidence-based approach with support and validation that each patient is achieving improved care engagement and outcomes. Prior to COVID-19, health systems had gaps of senior health system leadership commitment to telemedicine (mostly pilot activities and only about 10% doctors had used tele-health) and there were funding gaps, which now are mostly addressed. Over the last few years CMS added RPM with a $57 PPM to cover the technology and additional RPM and CCM complex chronic care and it’s making it so there is anywhere from $200-$340 billing per patient. IndividuALLytics® has built a business model around average of $200 PPM for MCC patients with a fully turnkey approach for devices/technology, support, administration, billing, and multi-disciplinary connect care, so doctors can help 100% of their MCC patients with improved care outcomes faster that also improves FTE productivity and earnings.IndividuALLyticsâ N-of-1 individual science, multi-disciplinary Connected Care, and on average $1,000 of patient device/technology financing covered by health insurance adds high value compared to group average science, mono-therapies, basic nurse/MA tele-care, and on average $300 of patient device/technology financing. IndividuALLytics® Supports The Best Care for 100% of Patients and Providers.
IndividuALLytics® N-of-1 individual science, multi-disciplinary Connected Care, and on average $1,000 of patient device/technology financing covered by health insurance adds high value compared to group average science, mono-therapies, basic nurse/MA tele-care, and on average $300 of patient device/technology financing. IndividuALLytics® Supports The Best Care for 100% of Patients and Providers.
Ready to learn more?
If you are interested in working with IndividuALLytics® to improve your patients’ health and quality of life and increase your earnings and savings while saving you time, we can schedule a short presentation to share more information and answer any questions.
Our program will provide a more personal, convenient, and successful healthcare experience. Click below to get in touch with us.